Want to join the conversation?
$BCR's consolidated net sales of oncology products in 2015 rose 3% (6% on a constant currency basis) from last year. The rise was primarily due to growth in sales of PICCs and was partially offset by declines in sales of Ports. U.S. sales of oncology products increased by 3% and International sales rose by 2% (13% on constant currency basis).
$NFLX a monster move, going up. Expect making some money on Monday.
$AMD down more than 6% even after posting above consensus third quarter results.
$MCD stock rose more than 2% after it posted better than expected 3Q16 results, driven by global same-store sales growth. Meanwhile, earnings and revenue were lower than last year, hurt by refranchising efforts.